Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$1.77B |
| 2 |
Uber
UBER
|
+$1.31B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.21B |
| 4 |
United Rentals
URI
|
+$1.05B |
| 5 |
Union Pacific
UNP
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$2.89B |
| 2 |
Amazon
AMZN
|
+$1.42B |
| 3 |
Sea Limited
SE
|
+$1.3B |
| 4 |
Stryker
SYK
|
+$1.15B |
| 5 |
Broadcom
AVGO
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 12.73% |
| 4 | Industrials | 12.04% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Nutrien
NTR
$32.1B
| $69.2M | 0.02% |
1,119,683
+572
| +0.1% | +$36.2K |
|
302
BWX Technologies
BWXT
$15.8B
| $68.6M | 0.02% |
914,657
-891,633
| -49% | -$64.4M |
|
303
Guardant Health
GH
$22.2B
| $68.2M | 0.02% |
2,301,472
+611,191
| +36% | +$21.5M |
|
304
Sarepta Therapeutics
SRPT
$1.94B
| $67.6M | 0.02% |
557,461
+78
| +0% | +$8.82K |
|
305
US Bancorp
USB
$101B
| $66.4M | 0.02% |
2,008,391
+990
| +0% | +$36.1K |
|
306
MSC Industrial Direct
MSM
$6.67B
| $66.3M | 0.02% |
675,000
+375,000
| +125% | +$37M |
|
307
Emerson Electric
EMR
$91.4B
| $66.2M | 0.02% |
685,299
+874
| +0.1% | +$83.2K |
|
308
Atkore
ATKR
$3.17B
| $65.9M | 0.02% |
441,406
-187,297
| -30% | -$28.3M |
|
309
Aurora
AUR
$13.5B
| $65.5M | 0.02% |
+27,887,433
| New | +$86.4M |
|
310
Hilltop Holdings
HTH
$2.25B
| $63.8M | 0.02% |
2,250,000
+1,050,000
| +88% | +$31.7M |
|
311
GSK
GSK
$101B
| $63.5M | 0.02% |
1,753,035
+685
| +0% | +$24.3K |
|
312
Silicon Laboratories
SLAB
$7.3B
| $62.5M | 0.02% |
539,450
+75,450
| +16% | +$10.4M |
|
|
FISV
313
Fiserv Inc
FISV
$27.4B
| $60.6M | 0.02% |
536,700
| – | – |
|
314
Atlassian
TEAM
$39.4B
| $59.8M | 0.02% |
296,539
-797,641
| -73% | -$151M |
|
315
Denali Therapeutics
DNLI
$4.04B
| $59.4M | 0.02% |
2,880,323
+42,671
| +2% | +$1.08M |
|
316
Insight Enterprises
NSIT
$4.54B
| $59.4M | 0.02% |
+407,986
| New | +$60.8M |
|
317
On Holding
ONON
$10.4B
| $55.1M | 0.02% |
1,980,610
| – | – |
|
|
CCC
318
CCC Intelligent Solutions
CCC
$4.11B
| $54.4M | 0.02% |
4,074,892
-3,230,696
| -44% | -$35.5M |
|
319
Steven Madden
SHOO
$3.49B
| $54.3M | 0.02% |
1,709,677
+355,707
| +26% | +$11.8M |
|
320
Encompass Health
EHC
$12.3B
| $52.9M | 0.01% |
787,849
| – | – |
|
321
Helmerich & Payne
HP
$4.29B
| $52.5M | 0.01% |
1,245,268
+194,298
| +18% | +$8.11M |
|
|
WRK
322
DELISTED
WestRock Company
WRK
| $51.8M | 0.01% |
1,445,754
+735
| +0.1% | +$24.1K |
|
323
Matsons
MATX
$6.41B
| $51.4M | 0.01% |
579,528
-8,674
| -1% | -$757K |
|
324
Comfort Systems
FIX
$61.2B
| $50.9M | 0.01% |
298,581
| – | – |
|
325
Brookfield Infrastructure
BIPC
$4.93B
| $50.2M | 0.01% |
1,419,614
-734,669
| -34% | -$30.3M |
|
Similar funds
Capital Research Global Investors's Q3 2023 Portfolio in Review
As of Q3 2023, Capital Research Global Investors held 434 positions worth $363B, down 2.7% from $373B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q3 2023 filing shows 20 new, 204 increased, 140 reduced and 23 closed positions. Its largest new stake was Uber: 28,763,300 shares worth $1.32B. The largest sale was Netflix, an estimated $2.89B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q3 2023 buy was Uber: 28,763,300 shares worth $1.32B.
- Capital Research Global Investors added most to Texas Instruments in Q3 2023, an estimated $1.77B increase.
- Capital Research Global Investors's biggest Q3 2023 reduction was Netflix, cutting an estimated $2.89B.
- Capital Research Global Investors fully exited Discover Financial Services in Q3 2023, selling an estimated $496M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $363B portfolio in Q3 2023.
- Capital Research Global Investors opened 20 new positions and closed 23 in Q3 2023.
- Capital Research Global Investors's portfolio value fell 2.7% quarter-over-quarter to $363B.
Based on Capital Research Global Investors's 13F filing for Q3 2023, filed 13 Nov 2023.